[HTML][HTML] Drug withdrawals from the Canadian market for safety reasons, 1963–2004
J Lexchin - Cmaj, 2005 - Can Med Assoc
Part of the process of identifying drugs withdrawn from the Canadian market for safety
reasons involved searching the CPS to see if products removed from the UK or US market …
reasons involved searching the CPS to see if products removed from the UK or US market …
[BOOK][B] Research networks involved in post-market pharmacosurveillance in the United States, United Kingdom, France, New Zealand, Australia, Norway and …
Our report highlights the role research networks can play in pharmacosurveillance and how
the knowledge they produce can be used by drug regulators and drug benefit plans …
the knowledge they produce can be used by drug regulators and drug benefit plans …
[PDF][PDF] Teaching of critical analysis of drug advertisements to medical students
Background: Medical practitioners utilize drug promotional materials from pharmaceutical
companies as a major source of information especially in developing countries. These …
companies as a major source of information especially in developing countries. These …
Withdrawals of drugs for safety reasons: How do regulators decide if they are too unsafe?
J Lexchin - Adverse Drug Reaction Bulletin, 2006 - journals.lww.com
Drugs cannot be guaranteed safe when they are approved by licensing authorities. Approval
is based on clinical trials of limited size and in selected patients. Subsequent data may …
is based on clinical trials of limited size and in selected patients. Subsequent data may …
A descriptive study evaluating Health Canada's risk communications
Purpose Risk assessment for natural health products (NHPs) may not be evaluated similarly
to therapeutic products by Health Canada in terms of notification of harms to consumers and …
to therapeutic products by Health Canada in terms of notification of harms to consumers and …
[BOOK][B] Commodification and medicalization of menopause: women's experiences with hormone replacement therapy
MP Patton - 2006 - tspace.library.utoronto.ca
My research investigates the power relations involved in the medicalization and
commodification of menopause and the many interests at stake beyond the health of …
commodification of menopause and the many interests at stake beyond the health of …
[CITATION][C] Réseaux de recherche engagés dans la pharmacovigilance après la commercialisation aux États-Unis, au Royaume-Uni, en France, en Nouvelle …
ME Wiktorowicz, J Lexchin, M Paterson… - 2000 - Institut canadien pour la sécurité des …